Raúl J. Andrade

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

EASL Clinical Practice Guidelines: Drug-induced liver injury

Raúl J. Andrade, Guruprasad P. Aithal, Einar S. Björnsson et al. · Journal of Hepatology · 2019 · 1.1K citations

Hepatology, Liver Physiology, Complications Of Cirrhosis +5

Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period

Raúl J. Andrade, M. Isabel Lucena, M. Carmen Fernández‐Santaella et al. · Gastroenterology · 2005 · 997 citations · Full text

Substance Abuse, Spanish Registry, Hepatology +11

Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

Vlad Ratziu, Stephen A. Harrison, Sven Francque et al. · Gastroenterology · 2016 · 993 citations · Full text

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients

Manuel Romero‐Gómez, María del Mar Viloria, Raúl J. Andrade et al. · Gastroenterology · 2005 · 730 citations · Full text

Metabolic Syndrome, Diabetes Management, Hepatology +12